Suven Life Sciences to present 'drug pipeline' at US meet
Hyderabad, Dec 11 (UNI) Suven Life Sciences Ltd Vice-Chairman and CEO Venkat Jasti will present Suven's drug discovery pipeline at Windhover's Bio/Pharma Partnerships Conference in San Francisco on December 13.
Windhover's Bio/Pharma Partnerships Conference provides a platform for the most promising innovator biotechnology and pharmaceutical companies to explore potential collaborations, alliances and financing activities.
Mr Jasti will also hold one-to-one meeting with various senior-level dealmakers for collaborations, financing initiatives and alliances, a press release here said.
Suven has been working on innovative technology platforms particularly in the class of selective 5-HT compounds for development as therapeutic agents in the treatment of euro-degenerative disorders like Alzheimer's, attention deficit and hyperactivity disorder, Huntington's Disease, Parkinsons and Schizophrenia.